Speakers:
Alek Adkins, MD, Michael Smith, PharmD, and Amy Vandenberg, PharmD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Alek Adkins, MD has indicated the presentation may include discussion of any off-label uses of a product.
Explanation Given: Potentially gabapentin for alcohol use disorder Buprenorphine & benzodiazepine co-administration
Michael Smith, PharmD has indicated the presentation may include discussion of any off-label uses of a product.
Explanation Given: Acetaminophen and non-steroidal anti-inflammatory drug off-label use for dental-related pain.
Amy Vandenberg, PharmD has indicated the presentation may include discussion of any off-label uses of a product.
Explanation Given: alternative treatments for anxiety (eg, prazosin, propranolol)
Planners and other Administrative Support:
Jill Fenske, MD has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.